3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
4
Multiple Myeloma
2
Vaccinia
1
Transplant-Related Hematologic Malignancy
1
Recurrence
1
Prostatic Neoplasms
1
Oligodendroglioma
1
Neoplasms
1
Medulloblastoma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Kidney Neoplasms
1
Hodgkin Disease
1
Glioma
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Interventions
Capecitabine
22
Oxaliplatin
19
Fluorouracil
16
Radiotherapy
11
Leucovorin
10
Cetuximab
9
Nivolumab
7
Bevacizumab
6
sintilimab
5
Specimen Handling
5
Radiotherapy, Intensity-Modulated
5
Magnetic Resonance Spectroscopy
5
Irinotecan
5
Folfox protocol
5
trifluridine tipiracil drug combination
4
pembrolizumab
4
Surgical Procedures, Operative
4
encorafenib
3
X-Rays
3
Trastuzumab
3
Surveys and Questionnaires
3
Sigmoidoscopy
3
Radiation
3
Pemetrexed
3
Gemcitabine
3
Endoscopy
3
Control Groups
3
Consolidation Chemotherapy
3
Cisplatin
3
Carboplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rectal Neoplasms
×
Granulocyte-Macrophage Colony-Stimulating Factor
×
90 days
×
Clear all
No trials found.